Table 1 Biopsy samples used in this study*.
| Controls (15 subjects, 28 tissues) | CD (13 patients, 27 tissues) | UC (19 patients, 29 tissues) | IBD (32 patients, 56 tissues) | |||||
|---|---|---|---|---|---|---|---|---|
| Site | End | Hist | End | Hist | End | Hist | End | Hist |
| Rectum | 0(13) | 0(13) | 5(13) | 5(13) | 9(10) | 9(10) | 14(23) | 14(23) |
| Caecum | 0(15) | 0(15) | 4(9) | 6(9) | 2(15) | 4(15) | 6(24) | 10(24) |
| Colon | 0(0) | 0(0) | 3(5) | 3(5) | 2(4) | 2(4) | 5(9) | 5(9) |
CD, Crohn's disease; End, endoscopic examination; Hist, histological examination; UC, ulcerative colitis.
*Endoscopic and histological examination was made on biopsy specimens, and only histologically positive samples were considered inflamed. Total numbers of biopsies for each group are presented in parentheses, and the numbers not in parentheses represent inflamed biopsies.